Correlation Between Mereo BioPharma and Nabriva Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Nabriva Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Nabriva Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Nabriva Therapeutics AG, you can compare the effects of market volatilities on Mereo BioPharma and Nabriva Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Nabriva Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Nabriva Therapeutics.

Diversification Opportunities for Mereo BioPharma and Nabriva Therapeutics

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Mereo and Nabriva is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Nabriva Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nabriva Therapeutics and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Nabriva Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nabriva Therapeutics has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Nabriva Therapeutics go up and down completely randomly.

Pair Corralation between Mereo BioPharma and Nabriva Therapeutics

If you would invest  162.00  in Nabriva Therapeutics AG on August 25, 2024 and sell it today you would earn a total of  0.00  from holding Nabriva Therapeutics AG or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.35%
ValuesDaily Returns

Mereo BioPharma Group  vs.  Nabriva Therapeutics AG

 Performance 
       Timeline  
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Nabriva Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nabriva Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Nabriva Therapeutics is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Mereo BioPharma and Nabriva Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mereo BioPharma and Nabriva Therapeutics

The main advantage of trading using opposite Mereo BioPharma and Nabriva Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Nabriva Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nabriva Therapeutics will offset losses from the drop in Nabriva Therapeutics' long position.
The idea behind Mereo BioPharma Group and Nabriva Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format